Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
12 hedge funds and large institutions have $1.01M invested in Yield10 Bioscience, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.
14% less funds holding
Funds holding: 14 → 12 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
77% less capital invested
Capital invested by funds: $4.35M → $1.01M (-$3.34M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$173K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$52.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$6.43K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$1.82M |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$427K |
| 3 |
Jane Street
New York
|
-$72K |
| 4 |
BlackRock
New York
|
-$31.3K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.77K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CC
1
Cannell & Co
New York
| $363K | – | – | – |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $257K | -$7.77K | -110 | -2% |
|
|
3
Millennium Management
New York
| $132K | +$173K | +2,449 | New |
|
4
Geode Capital Management
Boston,
Massachusetts
| $79K | – | – | – |
|
|
5
BlackRock
New York
| $71K | -$31.3K | -443 | -25% |
|
|
BC
6
Birchview Capital
Burlington,
Vermont
| $42K | – | – | – |
|
|
7
Citadel Advisors
Miami,
Florida
| $40K | +$52.6K | +745 | New |
|
|
8
UBS Group
Zurich,
Switzerland
| $12K | +$6.43K | +91 | +69% |
|
|
CWP
9
Concord Wealth Partners
Abingdon,
Virginia
| $8K | – | – | – |
|
|
IA
10
IFP Advisors
Tampa,
Florida
| $1K | – | – | – |
|
|
RMC
11
Resources Management Corp
West Hartford,
Connecticut
| $1K | – | – | – |
|
|
ACM
12
AIGH Capital Management
Baltimore,
Maryland
| – | -$1.82M | -14,320 | Closed |
|
|
WVP
13
Worth Venture Partners
Fort Lee,
New Jersey
| – | -$427K | -3,358 | Closed |
|
|
14
Jane Street
New York
| – | -$72K | -569 | Closed |
|
|
TRCT
15
Tower Research Capital (TRC)
New York
| – | -$6K | -46 | Closed |
|
YTEN Hedge Fund Activity: Q2 2022 in Review
12 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q2 2022, worth a combined $1.01M — down 77% from $4.35M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of YTEN and 2 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $173K. The largest seller was AIGH Capital Management, exiting entirely with an estimated $1.82M sold.
- 12 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q2 2022, down from 14 in Q1 2022.
- Funds reported $1.01M of Yield10 Bioscience, Inc. Common Stock stock for Q2 2022, down 77% quarter-over-quarter.
- 2 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q2 2022 and 4 closed out, a net change of -2 holders.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q2 2022 was Millennium Management, an estimated $173K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q2 2022 was AIGH Capital Management, an estimated $1.82M sold.
Based on aggregated 13F filings for Q2 2022.